JX-594

North America
We are currently recruiting for a clinical trial of JX-594 administered by intratumoral injection in patients with Stage 3 or Stage 4 unresectable malignant melanoma. For additional information about this study, please refer to the National Institutes of Health clinical trials database at http://www.clinicaltrials.gov.

JX-963

North America
Clinical trials with JX-963 will be initiated in North America in 2007. Information about these trials will be posted to the National Institutes of Health clinical trials database at http://www.clinicaltrials.gov.

JX-929

North America
Clinical trials with JX-929 will be initiated in North America in 2007. Information about these trials will be posted to the National Institutes of Health clinical trials database at http://www.clinicaltrials.gov.